Dynavax Technologies Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag – Yahoo Finance
Key Financial Results
Revenue: US$167.7m (up 55% from 3Q 2021).
Net income: US$63.8m (up from US$28.4m loss in 3Q 2021).
Profit margin: 38% (up from net loss in 3Q 2021). The move to profitability was primarily driven by higher revenue.
EPS: US$0.50 (up from US$0.24 loss in 3Q 2021).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Dynavax Technologies EPS Beats Expectations, Revenues Fall Short
Revenue missed analyst estimates by 1.6%. Earnings per share (EPS) exceeded analyst estimates by 31%.
Looking ahead, revenue is expected to decline by 16% p.a. on average during the next 3 years, while revenues in the Biotechs industry in the US are expected to grow by 14%.
Performance of the American Biotechs industry.
The company’s shares are up 7.1% from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Dynavax Technologies (1 is a bit concerning!) that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
Related Quotes
Dynavax Technologies (DVAX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Paratek Pharmaceuticals ( NASDAQ:PRTK ) Third Quarter 2022 Results Key Financial Results Revenue: US$30.2m (up 24% from…
Accuray ( NASDAQ:ARAY ) First Quarter 2023 Results Key Financial Results Revenue: US$96.5m (down 10% from 1Q 2022). Net…
Cerus ( NASDAQ:CERS ) Third Quarter 2022 Results Key Financial Results Revenue: US$39.6m (up 9.5% from 3Q 2021). Net…
Sangamo Therapeutics ( NASDAQ:SGMO ) Third Quarter 2022 Results Key Financial Results Revenue: US$26.5m (down 7.4% from…
Shares of Roku (NASDAQ: ROKU) were trading down 5% as of 10:49 a.m. ET on Wednesday, following a weaker-than-expected earnings report from Walt Disney. Roku stock has fallen nearly 80% year to date over worries of a slowing advertising market and weaker revenue growth. Disney's outlook didn't raise investors' hopes of a turnaround, which sent the stock to new lows.
Image source: The Motley Fool. Opko Health (NASDAQ: OPK)Q3 2022 Earnings CallNov 08, 2022, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood day, and welcome to the OPKO Health third quarter 2022 financial results conference call.
Kirby ( NYSE:KEX ) Third Quarter 2022 Results Key Financial Results Revenue: US$745.8m (up 25% from 3Q 2021). Net…
Sarcos Technology and Robotics Corporation (STRC) delivered earnings and revenue surprises of 14.29% and 8.49%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Evolus, Inc. (EOLS) delivered earnings and revenue surprises of -18.52% and 8.22%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
IRadimed ( NASDAQ:IRMD ) Third Quarter 2022 Results Key Financial Results Revenue: US$13.4m (up 23% from 3Q 2021). Net…
Kennametal ( NYSE:KMT ) First Quarter 2023 Results Key Financial Results Revenue: US$494.8m (up 2.3% from 1Q 2022). Net…
ShotSpotter (SSTI) delivered earnings and revenue surprises of -57.14% and 4.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
After the speakers' presentation, there will be a question-and-answer session [Operator instructions] Please be advised that today's conference is being recorded. My name is Bob Burrows, VP and IRO for the company. As is customary, today's call is open to all participants and the call is being recorded and is copyrighted by Emergent BioSolutions.
Despite a challenging year for the markets, this growth stock managed to stand out with another stellar quarter.
Shares of solid-state electric battery-maker QuantumScape (NYSE: QS) were in freefall today, down 14% as of 3:21 p.m EST. The company reported third-quarter earnings at the end of October, but today's move was likely caused by a big analyst downgrade, sending the stock even lower than many other EV stocks, which also generally had a bad day today. This morning, Morgan Stanley analyst Adam Jonas issued a note on QuantumScape, downgrading his rating to the equivalent of a "sell," while lowering his price target on the stock from $12 to just $4.
Electric vehicles have gone from a backwater industry to a full-blown revolution over the last few years. Spurred on by the huge growth of Tesla, companies have committed to investing tons of money into the fast-growing sector of the economy. Here's one electric vehicle (EV) stock to buy right now, and two that will likely be poor investments going forward.
Yahoo Finance reporter Pras Subramanian breaks down Rivian's Q3 earnings results.
Yahoo Finance's Pras Subramanian breaks down third-quarter earnings for Lucid.
Shares of Amazon (NASDAQ: AMZN) took another step down today, even though there was no company-specific news about the tech giant. Amazon stock finished the day down 4.3%, while the Nasdaq lost 2.5%. While Amazon doesn't have direct exposure to the layoffs at the Facebook parent or the collapse in the crypto market, it arguably has more exposure to consumer and business spending than any other company.